The "Anti-Obesity Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Anti-Obesity Drugs Market to Reach $4.8 Billion by 2030
The global market for Anti-Obesity Drugs estimated at US$2.7 Billion in the year 2023, is projected to reach a revised size of US$4.8 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030.
The anti-obesity drugs market faces significant unmet needs despite the availability of various medications. Current options include both short-term and long-term medications, as well as off-label drugs. Saxenda currently dominates the market, but newer drugs like semaglutide show promising potential in the pipeline.
Prescription Drugs, one of the segments analyzed in the report, is expected to record 8.5% CAGR and reach US$4.4 Billion by the end of the analysis period. Growth in the OTC Drugs segment is estimated at 10.9% CAGR for the next 7-year period.
Past setbacks have been experienced, but there are positive signs for drugs like Belviq, Xenical, and Contrave. However, reluctance among patients, physicians, and payers poses challenges to market growth, despite ongoing efforts in new drug development. Some diabetes drug companies are also exploring opportunities in the anti-obesity drugs space. Novo Nordisk leads the competitive landscape, particularly in the United States, which is the largest market for anti-obesity drugs.
The U.S. Market is Estimated at $827.9 Million, While China is Forecast to Grow at 7.9% CAGR
Europe presents vast potential, while obesity rates are rising in developing countries as well. In 2024, global key competitors share insights into market share distribution, reflecting the competitive dynamics of the industry.
The Anti-Obesity Drugs market in the U.S. is estimated at US$827.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$812.2 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.9% and 7.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.
Key Attributes:
Report Attribute | Details |
No. of Pages | 264 |
Forecast Period | 2023 - 2030 |
Estimated Market Value (USD) in 2023 | $2.7 Billion |
Forecasted Market Value (USD) by 2030 | $4.8 Billion |
Compound Annual Growth Rate | 8.7% |
Regions Covered | Global |
MARKET OVERVIEW
MARKET TRENDS & DRIVERS
FOCUS ON SELECT PLAYERS (Total 23 Featured)
For more information about this report visit https://www.researchandmarkets.com/r/qmmeud
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240509932174/en/
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900